13F

MLYS MINERALYS THERAPEUTICS INC

2026Q1 · CUSIP 603170101 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
214
Δ holders QoQ
-10
Breadth percentile
Top 86%
Whale holders
108
Δ whales
+3
Inst. holding value
$2.5B
New positions
33
Closed positions
43
Price momentum (1Q)
-5.5%
Put / Call
8/8

Breadth history (34 quarters)

2023Q2: Δ+5 · h=69 2023Q3: Δ+9 · h=78 2023Q4: Δ+10 · h=88 2024Q1: Δ+5 · h=93 2024Q2: Δ+2 · h=95 2024Q3: Δ+12 · h=107 2024Q4: Δ+5 · h=112 2025Q1: Δ+41 · h=153 2025Q2: Δ+15 · h=168 2025Q3: Δ+28 · h=196 2025Q4: Δ+28 · h=224 2026Q1: Δ-10 · h=214 2023Q2: holders=69 2023Q3: holders=78 2023Q4: holders=88 2024Q1: holders=93 2024Q2: holders=95 2024Q3: holders=107 2024Q4: holders=112 2025Q1: holders=153 2025Q2: holders=168 2025Q3: holders=196 2025Q4: holders=224 2026Q1: holders=214 -41 -20.5 +0 +20.5 +41 62149236 23Q223Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 18% -5.5%
2025Q3 Top 11% -36.6% -35.8%
2025Q1 Top 4% -5.5% +188.9%

Options Sentiment

Put holders
8
QoQ: 0
Call holders
8
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.97
EPS YoY
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2023-06-30: EPS -0.31 2023-09-30: EPS -0.57 2023-12-31: EPS -0.60 2024-03-31: EPS -0.70 2024-06-30: EPS -0.83 2024-09-30: EPS -1.13 2024-12-31: EPS -1.00 2025-03-31: EPS -0.79 2025-06-30: EPS -0.66 2025-09-30: EPS -0.52 2025-12-31: EPS -0.32 2026-03-31: EPS -0.47 -1.24 -0.62 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)